News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
June, 2025
June 2025
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
30  
Katsuaki Maehara: Immunotherapy trials in resectable NSCLC
Katsuaki Maehara/X
Jan 29, 2025, 22:05

Katsuaki Maehara: Immunotherapy trials in resectable NSCLC

Katsuaki Maehara, Director of Medical Education Colleagues, posted on X:

“Immunotherapy trials in resectable NSCLC.

Updated clinical data as of January, 2025.

KEYNOTE-671 – 4 year update.”

Katsuaki Maehara: Immunotherapy trials in resectable NSCLC

cancer Katsuaki Maehara NSCLC OncoDaily Oncology
Special Coverage
Oncolibrary
Jun 26, 2025, 14:50
What Is a Chemotherapy Port? Uses, Benefits and Complications
OncoDaily Pulse
Jun 26, 2025, 14:45
Yvonne Awards 2025: Honoring Global Oncology Leaders at ASCO’s Most Inspiring Night
Blog
Jun 26, 2025, 14:20
Sendurai Mani: Gratitude and Great Science at our Lab Retreat
Oncolibrary
Jun 26, 2025, 14:14
MASCC 2025 Highlights: MuReva OM Dramatically Reduces Severe Oral Mucositis in HNC
Oncolibrary
Jun 26, 2025, 14:12
MASCC 2025 Highlights: Key Toxicity Findings in ADC-Treated Cancer Patients
Blog
Jun 26, 2025, 14:05
Mieke Van Hemelrijck Joined EORTC Board and General Assembly Meetings 2025 in Brussels
Blog
Jun 26, 2025, 13:52
Tracey O’Brien Shared Rare Cancer Patient Hamish’s Story on 2025 Rare Cancers Awareness Day
Blog
Jun 26, 2025, 13:31
Yan Leyfman: Ejaculation Frequency Linked to Lower Prostate Cancer Risk
Insight
Jun 26, 2025, 13:15
Celebrating Innovation, Impact and Empathy in Cancer Care - 2025 CancerX Accelerator Showcase Honored 3 Standout Startups
Blog
Jun 26, 2025, 12:40
Sami Mansfield: How I Help Bridge the Gap in Patient-centered Care - 3 Actionable Strategies for Oncology Teams
Oncolibrary
Jun 26, 2025, 12:32
MASCC 2025: Sarcopenia and CT Fat Metrics Show No Survival Impact in NSCLC
Blog
Jun 26, 2025, 12:13
Andrei Nikiforchin: Honored to Contribute to the New Guideline on Gastric Cancer with Peritoneal Metastases